Addictive Disorders in Medical Populations
Drug and alcohol addictions occur commonly in medical populations; 25–50% of patients seen by primary care physicians have alcohol and drug disorders, with even higher prevalence in certain medical specialty populations. Drug use (including illicit drug use and actual or perceived misuse of prescribed medications), alcohol use, and what has been called unhealthy drinking are even more common in trauma centers and our society. Currently, there are no authoritative addiction texts that focus on the identification, intervention and management of either “addictive disorders in medical populations” or “medical complications in addiction populations”.
Neurobiological progress in the field of addiction has been amazing and evidence-based treatments have developed at a phenomenal pace, with bench to office applications for tobacco, alcohol and drugs. Pharmacological and psychosocial treatments are described here in detail and in practical terms. The medical and mental complications of addiction are explained comprehensively throughout the text. Clinical considerations are the predominant theme, with the standards of clinical practice grounded in the most current research. The chapters include practical presentations of both clinical and research materials, with instruments for screening and assessment and treatment.
It will be useful for all those seeking information to help a patient or family with a tobacco, alcohol or drug problem. We hope this book can give answers and direction to the identification and management of addictions and their medical complications in patient populations.
Part One Addictive Disorders and Medicine.
1 Addictive Disorders as an Integral Part of the Practice of Medicine (Norman S. Miller and Mark S. Gold).
2 Crime, Substance Use, and Mental Illness (Joel M. Silberberg, Milap A. Nowrangi, and Geetha Nampiaparampil).
3 Ethical Issues in Addiction Medicine (Roberta Springer Loewy).
4 Natural History of Addictive Diseases (Steven A. Branstetter and Sabina Low).
5 Prevention Methods: School, Family, Community, Media and Public Policy Approaches (Karol L. Kumpfer and Paula Smith).
Part Two Assessment and Diagnosis.
6 Screening and Diagnosis of Substance Use Disorders (Norman G. Hoffmann).
7 Clinical Pharmacology of Addicting Drugs (Jiang Liu and Hartmut Derendorf).
8 Laboratory Diagnosis of Addicting Drugs (K.P. Gunaga and Satheesh Gunaga).
9 Cutaneous Manifestations of Drug Addiction (Kendra Gail Bergstrom and Miguel R. Sanchez).
Part Three Addictive Disorders and Clinical Diseases.
10 Addictive Disorders in Primary Care Medicine (Robert Mallin).
11 Addictive Disorders in the Intensive Care Unit (Tracy R. Luckhardt and Robert C. Hyzy).
12 Addictive Disorders in Trauma Center Patients (Mary C. McCarthy and Kathryn M. Tchorz).
13 Addictive Disorders in Psychiatric Medicine (Christine Yuodelis-Flores, W. Murray Bennett, Charles Meredith, and Richard Ries).
14 Addiction and Short-Term Pain Management (Steven D. Passik, Lauren J. Rogak, Tatiana D. Starr, and Kenneth L. Kirsh).
15 Prescription Opiate Medications: Clinical Assessment and Treatment of Tolerance and Dependence (Norman S. Miller, Lucy Chen, and Jianren Mao).
16 Substance Addiction and HIV Infection: Scope of the Problem and Management (Gabriel Sarah, Clifford Martin, Myles Stone, Carol Schneiderman, and Stephen A. Klotz).
17 Addictive Disorders in Cardiovascular Medicine (Alan H. Gradman and Nosheen Javed).
18 Alcohol Use and Diseases of the Eye (Yoshimune Hiratsuka).
19 Addictive Disorders in Nutritional Diseases - From an Addictions Viewpoint (James A. Cocores, Noni A. Graham, and Mark S. Gold).
20 Addictive Disorders in Nutritional Diseases - From a Nutritional Viewpoint (Jennifer A. Nasser, Jessica B. Leitzsch, and Kiran Patel).
21 Gastrointestinal Diseases Associated with Substance Addiction (Paul S. Haber and Abdullah Demirkol).
22 Addictive Disorders in Malignant Diseases (Thomas J. Guzzo and Mark L. Gonzalgo).
23 Substance Addiction and Gastrointestinal Malignancy (Jason T. Hedrick and James R. Ouellette).
24 Renal Manifestations of Recreational Drug Use (Garland A. Campbell, W. Kline Bolton, and Mitchell H. Rosner).
25 Addictive Disorder in Urological Diseases (Herman S. Bagga and Adam W. Levinson).
Part Four Management of Addictive Disorders in Selected Populations.
26 Management of Addictive Disorders in Medical Nursing Care Populations (Kathleen L. Becker and Benita J. Walton-Moss).
27 Management of Addictive Disorders in Surgical Nursing Care Practice (Phyllis J. Mason).
28 Addictive Disorders in Psychology Practice (Lisa J. Merlo).
29 Addictive Disorders in Diseases of Women (Deborah V. Gross, C. Chapman Sledge, and Ellen A. Ovson).
30 Children and Adolescents with ADHD: Risk and Protective Factors for Addictive Disorders (Larry Gray, Jennifer J. Park, and Michael E. Msall).
31 Addictive Disorders in the Elderly (Andrea Bial).
Part Five Treatment of Addictive Disorders.
32 Pharmacological Therapeutics for Detoxification in Addictive Disorders (Firas H. Kobeissy, Carolina F. Braga, Noni A. Graham, and Mark S. Gold).
33 Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders (Lisa J. Merlo, Kimberly G. Blumenthal, Kendall Campbell, Morrow Omli, and Mark S. Gold).
34 Psychosocial Treatments for Addictive Disorders: Models, Settings, and Important Roles for Referring Physicians (John McKellar, John Finney, and Rudolf Moos).
35 Treatment Models for Comorbid Psychiatric and Addictive Disorders (Jon D. Kassel, Adrienne J. Heinz, Daniel P. Evatt, and Ashley R. Braun).
36 Brief Interventions for Alcohol and Drug Problems (Kristen L. Barry, Laurie Brockmann, and Frederic C. Blow).
37 Treatment Outcomes for Addictive Disorders (Erin L. Winstanley, Shannon K. Bolon, and Marc Fishman).
38 Biopsychosocial Recovery from Addictive Disorders (Sara Jo Nixon and Robert A. Prather).
He has published 250 medical/scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society for Addiction Medicine, and the American National Professional Committees. He is a member of the Task Force on Treatment for the Office of National Drug Control Policy, Office of the President of the United States; a member of the Center for Substance Abuse Treatment on Screening, Assessment, and Treatment Planning for patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research ing Substance Abuse. For the American Society for Addiction Medicine, he is Regional Director of the Midwest Region and Editor of Principles of Addiction Medicine (First Edition), Program and Publication Committees. He has coordinated symposia, courses and workshops for the ASAM annual meeting.
Mark S. Gold, M.D. is an editor, author, teacher, pioneer, researcher and inventor, who has worked for nearly 40 years to create models for understanding the effects of tobacco, opiates and other drugs on the brain and behavior. He has developed models that have led to the discovery of new addiction treatments and has conceptualized novel hypotheses which yielded new approaches to the definition and treatment of addictions. Dr. Gold's pioneering work on the brain systems underlying the effects of opiate drugs led to a dramatic change in the way opiate action was understood and his seminal work on cocaine is considered classic translational science. Over the past decade, he has defined hedonic overeating as an addiction and developed animal and imaging models to develop new treatments for overeating and obesity. Most recently, he and his colleagues demonstrated that intravenously administered anesthetics and analgesics are exhaled in the air of operating rooms, present on surfaces, and available for second hand exposure. Dr. Gold and colleagues have explained the role of the workplace environment in physician drug abuse, addictions and relapse after successful treatment. Under his leadership, the Department of Psychiatry at the University of Florida has grown to 60 full-time clinical physicians and researchers with new projects and research groups in secondhand exposure models, functional brain imaging, self-administration, public health, impaired professionals, genomics, proteomics and nanotechnology. Dr. Gold has been awarded numerous national prizes and recognition for his work, leadership, and mentoring. Since beginning his career in research at the University of Florida in 1970, he has been the author of over 900 medical articles, chapters, and abstracts in journals for health professionals on a wide variety of psychiatric research subjects and has authored 12 professional books including practice guidelines, ASAM core competencies, and medical text books for primary care professionals. He is the author of 15 general audience books. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), "Mark S. Gold, M.D. the most prolific and brilliant of the addiction experts writing today... Dr. Gold has spent his career trying to bridge the gap in medical education and practice with the belief that addictions are diseases and that all physicians have a critical role in prevention and, if that fails, in early identification and prompt treatment."
"Specific topics include ethical issues in addictive medicine, the clinical pharmacology of addictive drugs, addiction and short-term pain management, alcohol use and diseases of the eye, renal manifestations of recreational drug use, addictive disorders in the elderly, and brief interventions for alcohol and drug problems." (SciTech Book News, December 2010)